* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
2043	EPHA4	C0002736	Amyotrophic Lateral Sclerosis	0.400824180352639	BEFREE;HPO;ORPHANET
2043	EPHA4	C4022588	Fatigable weakness of swallowing muscles	0.2	HPO
2043	EPHA4	C0043352	Xerostomia	0.2	HPO
2043	EPHA4	C0085633	Mood swings	0.2	HPO
2043	EPHA4	C0234958	muscle degeneration	0.2	HPO
2043	EPHA4	C0030193	Pain	0.2	HPO
2043	EPHA4	C0027746	Nerve Degeneration	0.2	HPO
2043	EPHA4	C0026838	Muscle Spasticity	0.2	HPO
2043	EPHA4	C0026821	Muscle Cramp	0.2	HPO
2043	EPHA4	C0270948	Neurogenic Muscular Atrophy	0.2	HPO
2043	EPHA4	C0522224	Paralysed	0.2	HPO
2043	EPHA4	C0524851	Neurodegenerative Disorders	0.2	HPO
2043	EPHA4	C0541794	Skeletal muscle atrophy	0.2	HPO
2043	EPHA4	C0746674	Generalized muscle weakness	0.2	HPO
2043	EPHA4	C1145670	Respiratory Failure	0.2	HPO
2043	EPHA4	C0015672	Fatigue	0.2	HPO
2043	EPHA4	C0013404	Dyspnea	0.2	HPO
2043	EPHA4	C0011581	Depressive disorder	0.2	HPO
2043	EPHA4	C1843479	Neurogenic muscle atrophy, especially in the lower limbs	0.2	HPO
2043	EPHA4	C4020854	Neuro-degenerative disease	0.2	HPO
2043	EPHA4	C4020884	Anxiety disease	0.2	HPO
2043	EPHA4	C4022587	Fatigable weakness of respiratory muscles	0.2	HPO
2043	EPHA4	C0003467	Anxiety	0.2	HPO
2043	EPHA4	C0020429	Hyperalgesia	0.08	RGD
2043	EPHA4	C0752308	Hypoxia-Ischemia, Brain	0.08	RGD
2043	EPHA4	C0235032	Neurotoxicity Syndromes	0.08	RGD
2043	EPHA4	C0036920	Sezary Syndrome	0.00328236603323995	BEFREE;LHGDN
2043	EPHA4	C0001418	Adenocarcinoma	0.00300763924902685	BEFREE;LHGDN
2043	EPHA4	C0017636	Glioblastoma	0.00300763924902685	BEFREE;LHGDN
2043	EPHA4	C0027627	Neoplasm Metastasis	0.00273291246481375	LHGDN
2043	EPHA4	C0009404	Colorectal Neoplasms	0.00273291246481375	LHGDN
2043	EPHA4	C0030567	Parkinson Disease	0.002407028523288	GAD
2043	EPHA4	C0678222	Breast Carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0024623	Malignant neoplasm of stomach	0.0002747267842131	BEFREE
2043	EPHA4	C0684249	Carcinoma of lung	0.0002747267842131	BEFREE
2043	EPHA4	C0699791	Stomach Carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0020295	Hydronephrosis	0.0002747267842131	BEFREE
2043	EPHA4	C0017638	Glioma	0.0002747267842131	BEFREE
2043	EPHA4	C1306460	Primary malignant neoplasm of lung	0.0002747267842131	BEFREE
2043	EPHA4	C1335302	Pancreatic Ductal Adenocarcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C1527249	Colorectal Cancer	0.0002747267842131	BEFREE
2043	EPHA4	C2239176	Liver carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0009402	Colorectal Carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0006142	Malignant neoplasm of breast	0.0002747267842131	BEFREE
2043	EPHA4	C0004364	Autoimmune Diseases	0.0002747267842131	BEFREE
2043	EPHA4	C0000768	Congenital Abnormality	0.0002747267842131	BEFREE
2043	EPHA4	C4049615	Megaureter	0.0002747267842131	BEFREE
2043	EPHA4	C0281361	Adenocarcinoma of pancreas	0.0002747267842131	BEFREE
2043	EPHA4	C0079773	Lymphoma, T-Cell, Cutaneous	0.0002747267842131	BEFREE
2043	EPHA4	C0037274	Dermatologic disorders	0.0002747267842131	BEFREE
2043	EPHA4	C0152013	Adenocarcinoma of lung (disorder)	0.0002747267842131	BEFREE
2043	EPHA4	C0235974	Pancreatic carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0242379	Malignant neoplasm of lung	0.0002747267842131	BEFREE
2043	EPHA4	C0266258	Congenital absence of liver	0.0002747267842131	BEFREE
2043	EPHA4	C0026769	Multiple Sclerosis	0.0002747267842131	BEFREE
2043	EPHA4	C0278883	Metastatic melanoma	0.0002747267842131	BEFREE
2043	EPHA4	C0600139	Prostate carcinoma	0.0002747267842131	BEFREE
2043	EPHA4	C0346647	Malignant neoplasm of pancreas	0.0002747267842131	BEFREE
2043	EPHA4	C0376358	Malignant neoplasm of prostate	0.0002747267842131	BEFREE
2043	EPHA4	C0494165	Secondary malignant neoplasm of liver	0.0002747267842131	BEFREE
2043	EPHA4	C0521620	Dilatation of ureter	0.0002747267842131	BEFREE
2043	EPHA4	C0026764	Multiple Myeloma	0.0002747267842131	BEFREE
2043	EPHA4	C0025202	melanoma	0.0002747267842131	BEFREE
2043	EPHA4	C0041960	Ureterocele	0.0002747267842131	BEFREE